4//SEC Filing
Boudes Pol F 4
Accession 0001104659-20-005967
CIK 0001006281other
Filed
Jan 21, 7:00 PM ET
Accepted
Jan 22, 5:02 PM ET
Size
5.8 KB
Accession
0001104659-20-005967
Insider Transaction Report
Form 4
Boudes Pol F
Director
Transactions
- Award
Stock Options (Right to Buy)
2020-01-20+40,000→ 40,000 totalExercise: $3.55Exp: 2030-01-20→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]The shares of common stock underlying the stock options shall vest in 16 equal quarterly installments commencing upon the date of grant. The stock options are subject to accelerated vesting upon a corporate transaction or a change in control as described in the Protalix BioTherapeutics, Inc., 2006 Stock Incentive Plan, as amended.
Documents
Issuer
Protalix BioTherapeutics, Inc.
CIK 0001006281
Entity typeother
Related Parties
1- filerCIK 0001454771
Filing Metadata
- Form type
- 4
- Filed
- Jan 21, 7:00 PM ET
- Accepted
- Jan 22, 5:02 PM ET
- Size
- 5.8 KB